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Polyclonal antibodies were raised to synthetic amino acid sequences of the bovine GABAA receptor q- and as-subunits and purified by affinity 
chromatography on a column coupled with the respective peptide. Anti-peptide %(41&424) and anti-peptide aJ459-467) antibodies immunoprecip- 
itated GABAA receptors and recognized a protein of 53 kDa (PJ and 59 kDa (P& respectively, in Western blots of GABAA receptors purified 
from the brains of 5-10 day old rats. P,, as well as P,, are specifically photolabeled by PHlflunitrazepam and are recognized by the a-subunit 
specific monoclonal antibody bd 28. 
Antibody; GABA,-benzodiazepine receptor; Subunit; Heterogeneity 
1. INTRODUCTION 
y-Aminobutyric acid (GABA) is one of the quan- 
titatively most important neurotransmitters in the 
mamalian central nervous ystem. Most of the GABA 
actions are inhibitory and mediated by GABAA recep- 
tors. These receptors seem to consist of several protein 
subunits which form the GABA-gated chloride ion 
channel [l] and which possess allosteric binding sites 
for the anxiolytic benzodiazepines, for some bar- 
biturates, steroids and some convulsant chloride chan- 
nel ligands like picrotoxin and t-butylbicyclophos- 
phorothionate (TBPS) [2]. The GABAA-receptor has 
been purified to apparent homogeneity from several 
vertebrate species, and the molecular size of this recep- 
tor has been estimated to be 230-240 kDa [ 11. Original- 
ly, it has been assumed that the purified receptor 
preparation contains only two polypeptide chains, an CY- 
subunit of 50-53 kDa and a&subunit of 55-57 kDa [l]. 
Recently, however, using SDS-polyacrylamide gel elec- 
trophoresis with higher resolution, the existence of 
several different (Y- and&subunits of this receptor com- 
plex has been demonstrated [3]. The various a-subunits 
exhibit molecular weights of 50-60 kDa, can all be 
photolabeled by [3H]flunitrazepam and be recognized 
by the a-subunit specific monoclonal antibody bd 28. 
The &subunits exhibit molecular weights in the same 
molecular weight range as the a-subunits but can be 
photolabeled by the GABAA agonist [3H]muscimol and 
be recognized by the P-subunit specific monoclonal an- 
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tibody bd 17 [3]. Molecular cloning techniques sup- 
ported these studies by revealing the primary structures 
of several different LY- and &subunits of the 
GABAA-benzodiazepine receptor complex from the 
corresponding complementary DNAs [4,5]. Coinjec- 
tion into Xenopus oocytes of mRNAs of different IY- 
with that of the same P-subunit resulted in the expres- 
sion of GABA-gated chloride ion channels with dif- 
ferent GABA-sensitivity [4]. However, benzodiazepine 
sensitivity of expressed receptors was obtained only 
when the cDNAs of LY- and &subunits were used 
together with that of a newly identified y-subunit to 
transfect human embryonic kidney cells [6]. This seems 
to indicate that at least 3 different subunits are 
necessary to reconstitute GABAA-benzodiazepine 
receptors with correct pharmacology. 
In the present study the LYZ- and as-subunit proteins 
of GABAn-benzodiazepine receptors from the brains 
of 5-10 day old rats were identified by polyclonal an- 
tibodies directed against the C-terminal amino acid se- 
quence of the bovine LYZ or LYE primary structure [4]. 
2. MATERIALS AND METHODS 
The C-terminal nonapeptides of the LYZ- and cus-subunits, peptides 
~~~(416-424) (sequence CREPVLGVSP) and &459-467) (sequence 
CAIKGMIRKQ) were custom synthesized (Multiple Peptide Systems, 
San Diego, CA, USA) with an additional N-terminal cysteine each. 
Peptides were coupled to keyhole limpet hemocyanin (KLH) via the 
N-terminal cysteine [7] and peptide-KLH conjugates (1OO~g protein) 
emulsified with Freund’s complete adjuvant were injected at 3 sites 
subcutaneously into rabbits. Subsequent immunizations were in 
Freund’s incomplete adjuvant at three-week intervals. Animals were 
bled one and two weeks after the fourth and all subsequent immuniza- 
tions. All rabbits immunized produced antibodies recognizing the cor- 
responding peptide or GABAA receptors as measured by an ELISA, 
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using the peptides [8] or purified GABA,A receptor [9] as the antigen. 1 
The GABAA receptor was extracted from the brain of 5-10 day old 
rats and partially purified by affinity chromatography on Affigel 15 
(Bio-Rad, CA, USA) coupled to Ro 7-1986 as described previously 
[3]. In the partially purified receptor preparation the GABAA- 
benzodiazepine receptors were enriched at least lOOO-fold compared 
to the original membrane fractions. 
For immunoprecipitation [lo], aliquots of the purified receptor 
preparations were incubated in the presence of antibody at 4°C over- 
night. After addition of Immunoprecipitin (Bethesda Res. Lab, MD, 
USA) and shaking for an additional 3 h at 4”C, the precipitate was 
washed three times with buffer, and the amount of precipitated recep- 
tor was measured by a [‘Hlflunitrazepam binding assay [l 11. 
3. RESULTS AND DISCUSSION 
Anti-peptide ~~(416-424) and anti-peptide 
a3(459-467) antibodies were isolated from the sera of 
the rabbits by affinity chromatography on Thiopropyl- 
Sepharose 6B coupled to the cysteine residue of the 
respective peptides [ 121. Purified antibodies selectively 
recognized their respective peptide and the GABA*- 
receptor purified from the brains of 5-10 day old rats 
(table 1). The anti-peptide (~~(416-424) and the anti- 
peptide a3(459-467) antibodies were both able to 
recognize the receptor in a native conformation as 
demonstrated by immunoprecipitation experiments. 
Depending on the amount of purified antibody used, 
anti-peptide ~~~(416-424) or anti-peptide m3(459-467) 
were able to precipitate up to 54 or 44% of the GABAA 
receptor present in the incubation, respectively (ex- 
periments not shown). 
In addition, each of these antibodies reacted with 
purified GABAA receptor in Western blots. As can be 
seen from the fluorography in fig.1 (lane l), [3H]flu- 
nitrazepam specifically and irreversibly labeled at least 
3 different proteins with apparent molecular weights 5 1 
kDa (P5i), 53 kDa (Ps~) and 59 kDa (Psg) in receptor 
preparations purified from young animals [3,13]. In 
agreement with previous results [3] all 3 photolabeled 
Fig. 1. Comparison of proteins photolabeled by [“Hlflunitrazepam in 
a partially purified GABAA receptor preparation from young rats 
with those identified by several different antibodies. Partially purified 
GABAA receptors were specifically photolabeled by [“Hlfluni- 
trazepam and subjected to SDS-PAGE. Proteins were transferred to 
nitrocellulose and were either subjected to autoradiography (lane 1) 
or probed with the monoclonal antibody bd 28 (lane 2), the anti- 
peptide ~~~(416-424) (lane 3) or the anti-peptide ~(459-467) an- 
tibodies (lane 4) using the biotin-streptavidin horseradish peroxidase 
enhanced system from Amersham. The apparent molecular masses of 
the proteins were determined by calibrating the gel with standard pro- 
teins of known molecular weight. The arrows indicate proteins with 
apparent molecular weight 51 kDa (PSI), 53 kDa (Pr3) or 59 kDa (Pw). 
The experiment was performed 3 times with similar results. 
proteins were recognized by the a-subunit specific 
monoclonal antibody bd 28 (fig. 1, lane 2). In contrast, 
proteins PSJ or P59 were recognized selectively by the 
- Origin 
T 
-80 : 
Table 1 
ELISA demonstrating the recognition of immobilized peptides or affinity purified 
GABAA receptors by antibodies raised against a-subunit specific peptides 
Et450 nm) x 100 
Antibody 
(1 me, protein/ml) 
Dilution ~$416-424) ~(459-467) Purified 
receptor 
Anti-peptide ~(416-424) 1:lOO 224.4 n.d. 229.7 
1:lOOO 24.5 n.d. 131.4 
1:lOOOO 4.0 n.d. 36.1 
Anti-peptide (u3(459-467) 1:lOO n.d. 127.2 173.3 
1:lOOO n.d. 23.3 91.3 
1:lOOOO n.d. 0.1 10.4 
No primary antibody - 0.5 0.1 0.4 
GABAA receptor purified from the brains of 5-10 day old rats or peptides 
(~~(416-424) or (us(459-467) were coated into microtiter wells as described [8,9]. 
The immobilized antigens were then probed by various dilutions of anti-peptide an- 
tibodies and a subsequent ELISA method [9] using horseradish peroxidase- 
conjugated anti-rabbit IgG (BIOMAKOR, Rehovot Israel) and the TMB EIA 
horseradish peroxidase substrate kit (BIORAD, Richmond, CA, USA). The ex- 
periment was repeated three times with similar results. n.d., not detectable 
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anti-peptide ~~~(416-424) or the anti-peptide 
a3(459-467) antibody, respectively (fig. 1, lanes 3 and 
4). 
Since the antibodies used in the present study had 
been purified before according to their ability to 
recognize the immunizing peptide (see above), these 
data provide a direct link between the amino acid se- 
quence of the bovine (YZ- or as-subunit of the GABAA 
receptor and the proteins identified by the antibodies. 
Thus, the immunoprecipitation data indicate that 
epitopes are present in purified GABAA receptor from 
rat brain which are identical with or rather similar to 
those of the C-terminal amino acid structures of the CYZ- 
and cY3-subunits of the GABAA receptor from bovine 
brain. These epitopes seem to be associated with pro- 
teins P53 and PSS since these proteins were the only pro- 
teins recognized by the antipeptide ~~(416-424) and 
anti-peptide cu3(459-467) antibodies in this purified, 
receptor preparation, respectively, and since these pro- 
teins are associated with the GABAA-benzodiazepine 
receptor. This is indicated by the fact that proteins PSS 
and P59 are specifically photolabeled by [3H]fluni- 
trazepam and are recognized by the a-subunit selective 
antibody bd 28. Thus, the present results strongly sug- 
gest that proteins P53 and P59 are the CYZ- and as-sub- 
units of the GABAA-benzodiazepine receptor complex, 
respectively. 
Whereas the present results provide the first iden- 
tification of the cuz-subunit, a protein with an apparent 
molecular mass of 59-60 kDa has been identified 
recently in purified GABAA receptors from bovine 
brain by a polyclonal antibody directed against the C- 
terminal 14 amino acids of the bovine as-subunit [ 141. 
However, no attempt has been made to correlate this 
bovine protein with a protein photolabeled by 
[3H]flunitrazepam as in the present study. Protein PSS 
which is photolabeled by [3H]flunitrazepam and 
recognized by the anti-peptide a3(459-467) antibody, 
has been demonstrated previously to be associated with 
GABAA receptors (13,151. Its different regional 
distribution [15] and postnatal development [131 and 
the rather low potency of type I benzodiazepine recep- 
tor ligands for inhibition of [3H]ffu~tr~epam binding 
to this protein [13] indicated that this protein is 
associated with a subtype of the GABAA-benzo- 
diazepine receptor complex. 
Recent evidence [16] indicates that GABAA receptor 
subtypes with different benzodiazepin binding proper- 
ties can be constructed in human embryonic kidney cells 
transfected with a-, fl- and y-cDNAs and that the cy- 
and not the other subunits largely determine the phar- 
macological properties of type I or type II ben- 
zodiazepine receptors. In agreement with the conclu- 
sion drawn above, receptors containing the cus-subunits 
exhibit a much lower affinity for type I benzodiazepine 
receptor ligands than those ~ont~~ng the rur-subunits. 
54 
In the present investigation no data are provided on 
the possible identity of protein PSI. However, this pro- 
tein has been shown previously to be associated with the 
type I benzodi~epine receptor [17] and GABAA recep- 
tors cont~ning the al-subunit exhibit be~odi~epine 
binding properties closely similar to type I receptors in 
transfected human embryonic kidney cells [ 161. Since 
protein Psr [15] as well as the cur-subunit [4] seem to be 
the most abundant a-subunit of the GABAA receptor in 
cerebellum, a brain tissue especially enriched in type I 
benzodiazepine receptors [17], protein PSI possibly is 
identical with the tur-subunit of the GABAA receptor. 
This conclusion, however, has to be confirmed by 
cur-subunit selective antibodies. 
In summary, the present data indicate that proteins 
P53 and Ps9 specifically and irreversibly labeled by 
~3H]~u~trazepam are the (YZ- and ~3-subunits of the 
GABAA-b~odi~epine receptor, respectively. Using 
anti-peptide ~$416-424) and anti-peptide =3(459-467) 
antibodies, it should be possible to isolate and 
characterize the GABAA-benzodiazepine receptor sub- 
type associated with these subunits. 
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